Kester Nahen, PhD

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Kester Nahen, PhD, CEO of Notal Vision, discusses the patient self-operated AI-powered Scanly Home OCT device.

DENVER – Conversion from dry to wet age-related macular degeneration was detected in 82% of patients while they still had functional vision, through the use of Notal Vision’s ForeseeHome monitoring program.

DENVER – Conversion from dry to wet age-related macular degeneration was detected in 82% of patients while they still had functional vision, through the use of Notal Vision’s ForeseeHome monitoring program.